| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |